Washington has an estimated 120,000 patients over the age of 65 suffering from Alzheimer's.
says there are currently 120,000 Washingtonians aged 65 and older with Alzheimer’s. That number that is expected to grow nearly 17% by 2025 -- even if the drug only works for a third of patients, that’s still tens of thousands of people who could benefit.
In Washington, tens of thousands could be eligible for the drug according to ALZWA. Leqembi did get an accelerated approval process back in January, according to the FDA. Still, some medical experts are warning that this is not a cure and the drug won’t work for everyone, and for some, it also could have rough side effects.
“Our state is currently facing a workforce shortage for caregivers as well as folks working in longterm care facilities,” he told KIRO 7. “That is only going to grow as the baby boomers continue to age, and drugs like Leqembi will help to stem the growing of that crisis.”
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Fiona Phillips: How common is early Alzheimer's?We answer the questions you're asking about Alzheimer's disease, which causes dementia.
続きを読む »
One Type of Exercise Could Alleviate And Even Delay Alzheimer's SymptomsWorking on your muscles could help delay the onset of Alzheimer's symptoms, researchers have revealed.
続きを読む »
Fiona Phillips reveals she has Alzheimer's at 62The television presenter says she has dementia after battling brain fog and anxiety for months.
続きを読む »
Clonal hematopoiesis, aging and Alzheimer’s disease - Nature MedicineUnexpectedly, new data show that clonal hematopoiesis is associated with protection from Alzheimer’s disease; it is imperative that future studies unravel the complex tissue–disease contexts in which clonal hematopoiesis arises and contributes to aging-associated diseases.
続きを読む »
Silver Alert issued for missing 81-year-old Houston man with Alzheimer’sA Silver Alert was issued on Wednesday for a missing 81-year-old Houston man with Alzheimer’s.
続きを読む »